Single-cell approaches to tumor and immune cell heterogeneity
"First Institut Cancer et Immunologie summer school in immuno-oncology.
A program of excellence led by internationally renowned speakers."
The ICI Summer school, 2021 edition entirely in English, is designed for international PhD and Masters students in the fields of life sciences, medicine and informatics who are looking to deepen their knowledge and skills in the field of immuno-oncology research using the latest analytical methods. The Summer school will showcase recent technological breakthroughs that unravel the complexities of biological systems at the single-cell level, paving the way for the understanding of tumor and immune cell heterogeneity and the discovery of next-generation biomarkers and therapeutic targets.
The program is organized into five modules:
- A general introduction module that will familiarize participants with the latest concepts on cancer evolution in space and time, and the constraints that the local immune environment imposes on an evolving tumor.
- A single-cell sequencing module that will present the theory of high-throughput single-cell technologies for transcriptomic profiling of cells, and their applications in immuno-oncology research.
- A cytometry module that will familiarize students with mass, flow and spectral cytometry techniques for high-dimensional examination of the immune system in tumor tissue.
- A spatially-resolvedsingle-cell analysis module that will cover emerging cutting-edge technologies that add spatial resolution to single-cell signatures, as well as high-definition single-cell imaging methods that allow us to see how cells interact and function at the level of tumor tissues and whole organisms.
- A medical applications module will present how single-cell technologies are being applied in clinical practice, for diagnosis and treatment, and in industry for the discovery of new immunotherapy treatments for cancer.
- Hands-on workshops will be organized in small groups (2-3 people) to introduce students to the analysis of single-cell RNA-seq data.
- Throughout the week, registered students will actively participate in poster and paper presentations, as well as in round-table discussions where their questions and ideas will be discussed with keynote speakers and local and visiting professors.
- The Summer school will host 40 face-to-face CIVIS students (the number may vary depending on health regulations), and is also open to the wider scientific community via videoconference.
- Candidates must have some experience in oncology and immunology.
- Each student must bring a laptop computer.
- Our Summer school is designed for international PhD and Masters students in the fields of life sciences, medicine and informatics who wish to deepen their knowledge and skills in immuno-oncology research using the latest analytical methods.
- Non-local participants will be accommodated at Crous on the Luminy Campus site (see "Residents' Guide").
- Catering will be provided by the Crous.
Registration - Application deadline: April 15, 2021 Update: all scholarships will be funded by the student's university's CIVIS fund. Must provide the following information as part of their application:
- Curriculum Vitae,
- Cover letter (1 page) explaining your research interests and why you would like to attend the school,
- Transcripts showing grades received and ranking for the 2019-2020 academic year (NOT required for PhD students).
These documents must be uploaded in the application form below. https://formulaires.univ-amu.fr/fr/public/registration-form-1st-civis-s…
CIVIS is a European civic university formed by the alliance of nine of Europe's leading higher education and research institutions: Aix-Marseille Université, National and Kapodistrian University of Athens, Universitatea din București, Université libre de Bruxelles, Universidad Autónoma de Madrid, Sapienza Università di Roma, Stockholm University and Eberhard Karls Universität Tübingen and the University of Glasgow.
It brings together a community of over 384,000 students and 55,000 staff, including 30,000 academics and researchers.
- La Sapienza Università di Roma (Rome, Italy)
-Universidad Autonoma de Madrid (Madrid, Spain)
-Université Libre de Bruxelles (Brussels, Belgium)
-University of Bucharest (Bucharest, Romania)
- Fanny Mann, Chair (IBDM)
- Marie-dominique Franco (AMU-ICI)
- Aitor Gonzalez (TAGC)
- Cédric Maurange (IBDM)
- Pierre Milpied (CIML)
- Philippe Naquet (CIML)
- Sandrine Roulland (CIML)
- Cécile Vicier (CRCM-IPC)
- Stéphanie Bernard, administrative support (CRCM-IPC).
- Theodore Alexandrov EMBL, Germany.
- Ido Amit Weizmann Institute of Science, Israel
- Sabrina Baaklini CIML, France
- Philippe Bousso Institut Pasteur, France
- Horia Bumbea UMFCD, Romania
- Sabrina Carpentier Innate Pharma, France
- Christophe Caux CRCL, France
- Anne-Sophie Chrétien CRCM, France
- Régis Costello AP-HM, France
- Lisa Derosa Institut Gustave Roussy, France
- Vincent Detours ULB, Belgium
- Ali Ertürk iTERM Helmholtz, Germany
- Ivan Field Akoya Biosciences, France
- Jude Fitzgibbon Cancer Research Centre, Barts Centre, United Kingdom
- Jérôme Galon CRC, France
- Toby Lawrence CIML, France - KCL, United Kingdom.
- Hervé Luche CIPHE, France
- Cédric Maurange IBDM, France
- Fatima Mechta-Grigoriou Institut Curie, France
- Miriam Merad Icahn Mount Sinai NY, United States
- Simon Merz Miltenyi Biotec, France
- Pierre Milpied CIML, France
- Anne Rios Princess Maxima Center, The Netherlands
- Mikaël Roussel MICMAC, France
- Lionel Spinelli CIML, France
- Ali Tebbi Akoya Biosciences, France